down arrow

ARCpoint, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA03966D1078
CAD
0.01
0.00 (0.00%)

Dec 04

TSX

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Nova Leap Health Corp.
Innovotech, Inc.
Aion Therapeutic, Inc.
ARCpoint, Inc.
Jack Nathan Medical Corp.
BioMark Diagnostics, Inc.
Gemina Laboratories Ltd.
Akumin, Inc.
UniDoc Health Corp.
Telo Genomics Corp.
Awakn Life Sciences Corp.
Why is ARCpoint, Inc. ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -3.42
2
With a fall in Net Profit of -231.74%, the company declared Very Negative results in Mar 25
  • The company has declared negative results in Jan 70 after 3 consecutive negative quarters
  • NET SALES(HY) At CAD 1.69 MM has Grown at -63.84%
  • PRE-TAX PROFIT(Q) At CAD -1.16 MM has Fallen at -408.39%
  • NET PROFIT(Q) At CAD -0.91 MM has Fallen at -289.14%
3
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -83.33%, its profits have risen by 143.1%
4
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -83.33% returns in the last 1 year, the stock has also underperformed S&P/TSX 60 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is ARCpoint, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
ARCpoint, Inc.
-83.33%
-0.38
229.83%
S&P/TSX 60
19.1%
1.23
15.27%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
35.51%
EBIT Growth (5y)
-224.99%
EBIT to Interest (avg)
-3.42
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.17
Sales to Capital Employed (avg)
0.55
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
0
Industry P/E
Price to Book Value
-0.20
EV to EBIT
-2.98
EV to EBITDA
-3.55
EV to Capital Employed
10.22
EV to Sales
3.60
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-343.39%
ROE (Latest)
Negative BV
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company
NET PROFIT(HY)

At CAD -2.17 MM has Grown at 56.02%

DEBTORS TURNOVER RATIO(HY)

Highest at 5.72%

-15What is not working for the Company
NET SALES(HY)

At CAD 1.69 MM has Grown at -63.84%

PRE-TAX PROFIT(Q)

At CAD -1.16 MM has Fallen at -408.39%

NET PROFIT(Q)

At CAD -0.91 MM has Fallen at -289.14%

RAW MATERIAL COST(Y)

Grown by 613.15% (YoY

Here's what is working for ARCpoint, Inc.
Debtors Turnover Ratio
Highest at 5.72%
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Here's what is not working for ARCpoint, Inc.
Net Sales
At CAD 1.69 MM has Grown at -63.84%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very negative

Net Sales (CAD MM)

Pre-Tax Profit
At CAD -1.16 MM has Fallen at -408.39%
over average net sales of the previous four periods of CAD 0.38 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CAD MM)

Net Profit
At CAD -0.91 MM has Fallen at -289.14%
over average net sales of the previous four periods of CAD 0.48 MM
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (CAD MM)

Raw Material Cost
Grown by 613.15% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."